Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06029491 · ClinicalTrials.gov registry record · NA
The Pivotal Study of RapidPulseTM Aspiration System
A NA study of Acute Ischemic Stroke, sponsored by RapidPulse.
- Recruiting
- Registry status
- NA
- Development phase
- 170
- Enrollment target
- 20
- Study locations
NCT06029491: Recruiting NA study of Acute Ischemic Stroke, sponsored by RapidPulse.
NCT06029491 is a NA study of Acute Ischemic Stroke that is actively recruiting participants, run by RapidPulse. The registered enrollment target is 170 participants, below the 345-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (51% lower). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06029491, a NA study of Acute Ischemic Stroke, is actively recruiting participants, sponsored by RapidPulse.
- RECRUITING
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of this clinical trials is to demonstrate the safety and effectiveness for the RapidPulseTM Aspiration System in patients experiencing acute ischemic stroke within 8 hours of symptom onset or last seen normal. Subjects will undergo mechanical thrombectomy (a procedure to remove a clot in the brain which is preventing blood flow), with the RapidPulseTM Aspiration System. Participation in the trial is for 90 days.
Primary Outcome
The proportion of patients who achieve First Pass Reperfusion Effect (FPE) as defined by mTICI ≥ 2c after the first pass
Conditions Studied
Interventions
- DEVICE RapidPulseTM Aspiration System
Study Locations (20)
Florida
- Baptist Health Research Institute - Jacksonville
- University of South Florida - Tampa
Illinois
- Rush University Medical Center - Chicago
- Advocate Aurora Research Institute - Park Ridge
New York
- State University of New York at Buffalo - Buffalo
- Icahn School of Medicine at Mount Sinai - New York
Tennessee
- Semmes Murphey Foundation - Baptist Memorial Hospital - Memphis
- Vanderbilt University Medical Center - Nashville
Other
- Centre Hospitalier Universitaire de Bordeaux - Bordeaux
- Centre Hospitalier Universitaire de Montpellier - Montpellier
California
- Providence Saint John's Medical Foundation - Torrance
Connecticut
- Yale University - New Haven
Georgia
- Emory University at Grady - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2025-03-27 |
| Est. Completion | 2027-04 |
| Phase | NA |
What NCT06029491 shows while recruiting
NCT06029491 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 345-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (51% lower).
The record links to 1 condition, with Acute Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which RapidPulseTM Aspiration System is the first listed.
NCT06029491 names 20 study sites across 15 states, led by Florida, Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT06029491 about?
NCT06029491 is a clinical study titled "The Pivotal Study of RapidPulseTM Aspiration System". The goal of this clinical trials is to demonstrate the safety and effectiveness for the RapidPulseTM Aspiration System in patients experiencing acute ischemic stroke within 8 hours of symptom onset or last seen normal. Subjects will undergo mechanical thrombectomy (a procedure to remove a clot in th...
What is the current status of trial NCT06029491?
This trial is currently recruiting. It is a NA study. The enrollment target is 170 participants. The study started on 2025-03-27. Estimated completion is 2027-04.
What conditions does trial NCT06029491 study?
This clinical trial studies the following conditions: Acute Ischemic Stroke.
What interventions are being tested in trial NCT06029491?
The interventions under investigation include: RapidPulseTM Aspiration System (DEVICE).
Who is sponsoring clinical trial NCT06029491?
This trial is sponsored by RapidPulse, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06029491 being conducted?
This trial has 20 study locations across California, Connecticut, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06029491's enrollment target sits among peer trials
170 14th of 25 higher than 12 of 25 other Acute Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke
RECRUITING · NA
-
Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
RECRUITING · NA
-
An EFS to Evaluate the CGuard Prime™ Carotid Stent in Acute Ischemic Stroke
ACTIVE NOT RECRUITING · NA
-
Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI
ACTIVE NOT RECRUITING · NA
-
EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)
ACTIVE NOT RECRUITING · NA
-
Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI